Literature DB >> 20164854

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.

S Medves, F P Duhoux, A Ferrant, F Toffalini, G Ameye, J-M Libouton, H A Poirel, J-B Demoulin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20164854     DOI： 10.1038/leu.2010.13

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κB.

Authors:  Carmen P Montano-Almendras; Ahmed Essaghir; Hélène Schoemans; Inci Varis; Laura A Noël; Amélie I Velghe; Dominique Latinne; Laurent Knoops; Jean-Baptiste Demoulin
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.

Authors:  A Alholle; A T Brini; J Bauer; S Gharanei; S Niada; A Slater; D Gentle; E R Maher; L Jeys; R Grimer; V P Sumathi; F Latif
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

3.  Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis.

Authors:  Jean-Baptiste Demoulin; Carmen P Montano-Almendras
Journal:  Am J Blood Res       Date:  2012-01-01

4.  The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.

Authors:  Laura A Noël; Florence A Arts; Carmen P Montano-Almendras; Luk Cox; Olga Gielen; Federica Toffalini; Catherine Y Marbehant; Jan Cools; Jean-Baptiste Demoulin
Journal:  Mol Oncol       Date:  2014-02-17       Impact factor: 6.603

5.  A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Authors:  Zhaohui Du; Niels Weinhold; Gregory Chi Song; Kristin A Rand; David J Van Den Berg; Amie E Hwang; Xin Sheng; Victor Hom; Sikander Ailawadhi; Ajay K Nooka; Seema Singhal; Karen Pawlish; Edward S Peters; Cathryn Bock; Ann Mohrbacher; Alexander Stram; Sonja I Berndt; William J Blot; Graham Casey; Victoria L Stevens; Rick Kittles; Phyllis J Goodman; W Ryan Diver; Anselm Hennis; Barbara Nemesure; Eric A Klein; Benjamin A Rybicki; Janet L Stanford; John S Witte; Lisa Signorello; Esther M John; Leslie Bernstein; Antoinette M Stroup; Owen W Stephens; Maurizio Zangari; Frits Van Rhee; Andrew Olshan; Wei Zheng; Jennifer J Hu; Regina Ziegler; Sarah J Nyante; Sue Ann Ingles; Michael F Press; John David Carpten; Stephen J Chanock; Jayesh Mehta; Graham A Colditz; Jeffrey Wolf; Thomas G Martin; Michael Tomasson; Mark A Fiala; Howard Terebelo; Nalini Janakiraman; Laurence Kolonel; Kenneth C Anderson; Loic Le Marchand; Daniel Auclair; Brian C-H Chiu; Elad Ziv; Daniel Stram; Ravi Vij; Leon Bernal-Mizrachi; Gareth J Morgan; Jeffrey A Zonder; Carol Ann Huff; Sagar Lonial; Robert Z Orlowski; David V Conti; Christopher A Haiman; Wendy Cozen
Journal:  Blood Adv       Date:  2020-01-14

6.  Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK.

Authors:  Sandrine Medves; Laura A Noël; Carmen P Montano-Almendras; Roxana I Albu; Hélène Schoemans; Stefan N Constantinescu; Jean-Baptiste Demoulin
Journal:  Haematologica       Date:  2011-06-17       Impact factor: 9.941

7.  Penttinen syndrome-associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling.

Authors:  Audrey Nédélec; Emilie M Guérit; Guillaume Dachy; Sandrine Lenglez; Lok San Wong; Florence A Arts; Jean-Baptiste Demoulin
Journal:  J Cell Mol Med       Date:  2022-06-10       Impact factor: 5.295

8.  Somatic uniparental isodisomy explains multifocality of glomuvenous malformations.

Authors:  Mustapha Amyere; Virginie Aerts; Pascal Brouillard; Brendan A S McIntyre; François P Duhoux; Michel Wassef; Odile Enjolras; John B Mulliken; Olivier Devuyst; Hélène Antoine-Poirel; Laurence M Boon; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2013-01-31       Impact factor: 11.025

9.  PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.

Authors:  F A Arts; D Chand; C Pecquet; A I Velghe; S Constantinescu; B Hallberg; J-B Demoulin
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

Review 10.  Targeting the PDGF signaling pathway in tumor treatment.

Authors:  Carl-Henrik Heldin
Journal:  Cell Commun Signal       Date:  2013-12-20       Impact factor: 5.712
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.